Google Cloud scores 6-year run with IDN reorienting toward tech-enabled patient experience

An integrated delivery network that covers five and a half million lives is bringing in Google Cloud to help build and maintain a patient-centric platform with advanced analytic and AI capabilities.

Pittsburgh-based Highmark Health is announcing the engagement will run for six years.

The organization, which has members in West Virginia and Delaware as well as Pennsylvania, says it’s looking to defragment the patient experience “with a more coordinated, personalized, technology-enabled” model.

It also wants to use data to unburden clinicians of administrative tasks and supply them with meaningful patient information.

Highmark Health will control access to the platform and, together with Google Cloud, form a review board to oversee data ethics and privacy.

Highmark says it’s creating around 125 new jobs to support the platform’s development. Most of the hires will be placed in application development, cloud-based computing architectures, analytics and user experience design.

Karen Hanlon, Highmark Health’s executive vice president and COO, says the organization arrived at this point after considering how the “entire health experience should be re-engineered with [patients] at the center. … [W]e had to change our organization by breaking down old paradigms and barriers, leveraging resources across our enterprise and bringing a differentiated approach to healthcare, which includes the development of a powerful technology platform to turbo-charge the model.”

Andrew Moore, VP of industry solutions at Google Cloud, adds that the “combination of Highmark Health’s deep understanding of patient behavior and clinical best practices with Google Cloud’s technology capabilities, including artificial Intelligence and machine learning expertise, will accelerate access to the most cutting-edge tools for people to improve their health.”

Full announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.